Reversing not only cancer, but autism, autoimmune diseases, Alzheimer's, multiple sclerosis, kidney disease, HIV and other chronic illnesses.
Gc proteins, which are naturally present in the human body, are used by the body and combined with unsaturated fatty acids (e.g. oleic acid) and vitamin D3 to create GcMAF proteins.
Vitamin D-binding protein, also known as gc-globulin (group-specific component), is a protein that in humans is encoded by the GC gene.
The 'drug', however, is entirely natural and is composed of a special protein molecule combined with an unsaturated fatty acid (oleic acid) and vitamin D. The resulting complex molecule, GcMAF, needs enzymes produced by probiotic bacteria to be activated. The full treatment protocol, entitled the 'Swiss Protocol', includes a non-inflammatory diet (paleo-ketogenic diet), a special blend of probiotics, other supplements and amino acids. The protocol is offered to patients so far by Immuno Biotech in Switzerland and Germany. (Source: WDDTY)
A special blend of probiotics, equal or similar to the blend in human colostrum (mother's first milk), create enzymes, which then activate the GcMAF super-protein molecule, 'What Doctors Don't Tell You' magazine writes.
Gc proteins, which are naturally present in the human body, are used by the body and combined with unsaturated fatty acids (e.g. oleic acid) and vitamin D3 to create GcMAF proteins. Vitamin D-binding protein, also known as gc-globulin (group-specific component), is a protein that in humans is encoded by the GC gene.
The GcMAF protein then boosts the immune system, and enables macrophages (white blood cells) to do their job properly, i.e. to clean up cancer cells, attack tumors by making their surrounding cells excrete nitric oxide gas, eliminate viruses, etc. (Source: What Doctors Don't Tell You)
What is most intriguing about this discovery, in my opinion, is that it provides further evidence and information on why many claimed natural cancer remedies may work. If cancer, viruses and many other chronic illnesses can be overcome naturally by the body when the immune system is working at optimal capacity, then research into topics, such as vitamin C mega-dosing, Bob Beck protocol (including blood electrification), ozone therapies and other methods which also claim to work by maximising the efficiency of the immune system (while being cheaper than GcMAF) becomes increasingly important and fascinating.
Professor Ruggiero developed some new diagnosis tools as well, which help immensely with the detection and treatment of both cancer and autism. Ultrasonography can be used to accurately locate and measure tumors so that GcMAF can be placed directly on the tumor, the Medlab magazine says. Transcranial ultrasonography can be used to detect, measure and classify autism in children as young as three months old.
For the first time in autism history, autism spectrum disorder can be diagnosed in babies. This will allow specialists to intervene from an early age to avoid or revert the onset of autism. (2)
In addition, nagalase blood tests can be used to determine whether someone is at an increased risk of cancer. (3)
- "For stage one, a standard dose of 0.25ml GOleic twice a week, for stage 2 three doses a week, late stage 4 up to a full 1ml a day. The more the better. 2ml a day has been taken without side effects."
- "10,000 iu of vitamin D a day"
- "Eat white meat, fish and vegetables"
- "No sugar or carbohydrates (so no cereals or bread etc) which feed cancer"
- "If your weight drops below your perfect weight for your height, take Branch Chain Amino Acids (BCAA) from a vitamin shop, or better, Master Amino Acid Pattern (MAP) from Dr Reinwald Healthcare."
Published with consent from 'What Doctors Don't Tell You' magazine.
(2) Medlab Magazine: "The Blood Protein with Multiple Benefits"
(3) The GcMAF Book by Dr. Timothy J. Smith
Lets save the cancer world together research paper by research paper and test by test. Some cutting edge papers. I should be asleep, but this is just too important!
The devil I referred to in yesterdays blog is one of the authors of this paper. I note some signficant clinical successes with colorectal cancer. If you are interested in the evolution of these cancer treatments just goto pubmed and search for HAMLET and CANCER.
This blog is largely supportive of GCMAF and the Clinic despite my lack of success with Goleic OA GcMAF and thecompanies failings, as with cancer time is friend and enemy. You decide, I am jsut sharing my experience, I feel its of particular relevance to anyone interested in an integrative immune response. Oh and the dietary therapy is crap, they tell you to go google low carb, aim at 65% protein and give you some crapped low carb nibblies. No guidance at all about fat, carb, protein ratios in common foods, no explanation about the science of ketosis and why the diets essential. I have written about these many times over the years. They did not measure my weight, or my friends at the beginning or end of the clinic visit. Just lots of little details that I think would add what I call clinical rigour to whats been claimed, but that might take effort and get in the way of sales.
CLINICAL EXPERIENCE OF CANCER IMMUNOTHERAPY INTEGRATED WITH OLEIC ACID COMPLEXED WITH DE-GLYCOSYLATED VITAMIN D BINDING PROTEIN
Proteins highly represented in milk such as α-lactalbumin and lactoferrin bind Oleic Acid (OA) to form
complexes with selective anti-tumor activity. A protein present in milk, colostrum and blood, vitamin D
binding protein is the precursor of a potent Macrophage Activating Factor (GcMAF) and in analogy with other OA-protein complexes, we proposed that OA-GcMAF could demonstrate a greater
immunotherapeutic activity than that of GcMAF alone. We describe a preliminary experience treating
patients with advanced cancers, often labelled as “incurable” with an integrative immunotherapy centred on OA-GcMAF. Patients with advanced cancer were treated at the Immuno Biotech Treatment Centre with OA-GcMAF-based integrative immunotherapy in combination with a very low carbohydrate, high protein diet, fermented milk products containing naturally produced GcMAF, vitamin D3 and low-dose acetylsalicylic acid. When the primary tumor or a metastasis could be measured by ultrasonographic techniques, we observed, on average, a decrease of tumor volume of approximately 25% in a week. We also observed a consistent increase in splenic blood flow that was interpreted in the context of generalised immune system activation and allowed to assess the degree of responsiveness of the individual patient. The results reported here are consistent with the results previously described in the experimental animal harbouring a human hepatocellular carcinoma as well as with the results reported for neoadjuvant chemotherapy. OA-protein complexes are bound to play a leading role in cancer therapy thanks toselectivity of antitumoral effects, absence of any side effects, safety and oral availability. We hypothesise that OA-GcMAF, combines the known anticancer
effects OA-protein complexes with the well established immune stimulating effects of GcMAF.
If you follow the blog, you will know about my lack of response at the GCMAF Clinic, calling it a clinic from my experience is a disservice to most cancer clinics, but alas they have a service and product that works. That if you on the edge of existence then you need to try before you die. I have seen it work in many, some close friends. I have also seen a few have no responses, unfortunately myself. I am seeking answers for the no response in my various investigations, I have some promising leads.
One day I will deliver equivalent formulas for a bravo style probiotic yogurt, alas until that day, its the best option that costs 600 euro for 3 months supply.
The road to clinical use of high-intensity focused ultrasound for liver cancer: technical and clinical consensus
Some nice support at colonchat
Germany excellence in science, medicine and innovation and legislation.Its the best chance we have got, I have got!
he tiny U.S. biotech received a special "hospital exemption" in Germany, allowing Northwest to sell the injectable drug for five years even though it has not completed its late-stage trial of the immunotherapy.